Annual Drug Patent Expirations for QINLOCK Qinlock is a drug marketed by Deciphera Pharms and is included in one NDA. It is available from one supplier. There are twenty-two patents…
The post New patent for Deciphera Pharms drug QINLOCK appeared first …
This chart shows the pharmaceutical companies with the most patents in Brazil. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…
The post Which pharmaceutical companies have the most drug paten…
Which pharmaceutical companies have the most drug patents in Brazil? Read Post »
Annual Drug Patent Expirations for TAFINLAR Tafinlar is a drug marketed by Novartis and is included in two NDAs. It is available from one supplier. There are twelve patents protecting…
The post New patent for Novartis drug TAFINLAR appeared first on Dr…
Annual Drug Patent Expirations for ZURZUVAE Zurzuvae is a drug marketed by Biogen Inc and is included in one NDA. It is available from one supplier. There are four patents…
The post New patent for Biogen Inc drug ZURZUVAE appeared first on DrugPatentWa…
Annual Drug Patent Expirations for FILSUVEZ Filsuvez is a drug marketed by Amryt and is included in one NDA. It is available from one supplier. The generic ingredient in FILSUVEZ…
The post New patent for AMRYT drug FILSUVEZ appeared first on DrugPatent…
Annual Drug Patent Expirations for PIQRAY Piqray is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are two patents protecting…
The post New patent for Novartis drug PIQRAY appeared first on DrugPatentWa…
Annual Drug Patent Expirations for TRELEGY+ELLIPTA Trelegy Ellipta is a drug marketed by Glaxosmithkline and is included in one NDA. It is available from one supplier. There are fourteen patents…
The post New patent for Glaxosmithkline drug TRELEGY ELL…
New patent for Glaxosmithkline drug TRELEGY ELLIPTA Read Post »
Annual Drug Patent Expirations for INCRUSE+ELLIPTA Incruse Ellipta is a drug marketed by Glaxo Grp England and is included in one NDA. It is available from one supplier. There are…
The post New patent for Glaxo Grp drug INCRUSE ELLIPTA appeared first o…
This chart shows the pharmaceutical companies with the most patents in South Korea. Patents must be filed in each country (or, in some cases regional patent office) where patent protection…
The post Which pharmaceutical companies have the most drug pat…
Which pharmaceutical companies have the most drug patents in South Korea? Read Post »
Switching pharmaceutical excipients, the inactive components used in drug formulations, can have significant implications for both production costs and market appeal. These components, while not contributing directly to the therapeutic…
The post Cost-C…
Cost-Cut Without Compromise: Navigating Excipient Switching in Pharma Read Post »
Get new actionable insights and updates from BiotechBlog
